nature semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons Nature - Nature Reviews Gastroenterology

doi: 10.1016/j.lfs.2019.117152

ZEPBOUND BEATS WEGOVY IN BATTLE OF WEIGHT-LOSS DRUG TITANS Head-to-head trial finds both drugs are effective, but Zepbound is superior Texas Telemedicine Doctor June 2025 June 2025 Three GLP-1 drugs, Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide), are currently approved for weight loss

If your prescriber recommends a compounded therapy, ask specifically whether a 503B-registered facility can fill it

Retrieved from Lewis, Stephen, Cochrane, San

Key Takeaways: Ozempic and Wegovy contain semaglutide, a GLP-1 medication prescribed for chronic weight management when clinically appropriate Once-weekly injections help reduce appetite, improve fullness, and support sustainable weight loss Physician-supervised program with personalized dosing and ongoing monitoring Available in Miami, FL via telehealth and in-office consultations Insurance verification support and transparent self-pay options available Prescription required after medical evaluation